Case number 1:23-cv-01286
Harmony Biosciences, LLC et al v. Lupin Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 28, 2024 | 77 | NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions filed by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC.(Tigan, Jeremy) (Entered: 06/28/2024) (3) |
| Jun 28, 2024 | 76 | NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions filed by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC.(Tigan, Jeremy) (Entered: 06/28/2024) (3) |
| Jun 28, 2024 | 75 | NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions filed by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC.(Tigan, Jeremy) (Entered: 06/28/2024) (3) |
| Jun 28, 2024 | 74 | NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions filed by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC.(Tigan, Jeremy) (Entered: 06/28/2024) (3) |
| Jun 28, 2024 | 73 | NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions filed by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC.(Tigan, Jeremy) (Entered: 06/28/2024) (4) |
| Jun 28, 2024 | 72 | NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions filed by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC.(Tigan, Jeremy) (Entered: 06/28/2024) (3) |
| Jun 20, 2024 | 71 | REDACTED VERSION of 67 Letter, by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Proposed Order)(Tigan, Jeremy) (Entered: 06/20/2024) (0) |
| Jun 13, 2024 | 70 | Letter to The Honorable Sherry R. Fallon from Dominick T. Gattuso, Esq. re 67 Letter. (Attachments: # 1 Exhibit 1-5)(Gattuso, Dominick) Modified on 6/13/2024 (lih). (Entered: 06/13/2024) (0) |
| Jun 13, 2024 | 69 | Letter to The Honorable Sherry R. Fallon from Jeremy A. Tigan re 68 Letter. (Attachments: # 1 Ex. I, # 2 Ex. J, # 3 Ex. K, # 4 Ex. L)(Tigan, Jeremy) Modified on 6/13/2024 (lih). (Entered: 06/13/2024) (0) |
| Jun 12, 2024 | 68 | Letter to The Honorable Sherry R. Fallon from Dominick T. Gattuso, Esquire regarding Discovery Dispute. (Gattuso, Dominick) (Entered: 06/12/2024) (3) |
| Jun 12, 2024 | 67 | [SEALED] Letter to The Honorable Sherry R. Fallon from Jeremy A. Tigan regarding Protective Order Dispute . (Attachments: # 1 Ex. A, # 2 Ex. B, # 3 Ex. C, # 4 Ex. D, # 5 Ex. E, # 6 Ex. F, # 7 Ex. G, # 8 Ex. H, # 9 Proposed Order)(Tigan, Jeremy) Modified on 6/12/2024 (lih). (Entered: 06/12/2024) (0) |
| Jun 7, 2024 | 66 | ORAL ORDER- GRANTING-IN-PART 64 Joint MOTION for Teleconference to Resolve Protective Order Disputes. A discovery dispute motion hearing shall be set at the convenience of the court once the discovery dispute is fully briefed if the court deems it necessary. The parties shall follow the Discovery Matters and Disputes procedure as set forth in the Order regarding discovery matters available at www.ded.uscourts.gov/judge/magistrate-judge-sherry-r-fallon. Set Deadlines: (Moving submission due by no later than 11:00 a.m. on 6/12/2024, Responsive submission due by no later than 11:00 a.m. on 6/13/2024). Ordered by Judge Sherry R. Fallon on 6/7/2024. (lih) (Entered: 06/07/2024) (0) |
| Jun 7, 2024 | 65 | ORAL ORDER REFERRING MOTION: IT IS HEREBY ORDERED that the Joint Motion for Teleconference to Resolve Protective Order Disputes (D.I. 64 ) is now REFERRED to Magistrate Judge Sherry R. Fallon. Ordered by Judge Jennifer L. Hall on 6/7/2024. (ceg) Modified on 6/7/2024 (ceg). (Entered: 06/07/2024) (0) |
| Jun 6, 2024 | 64 | Joint MOTION for Teleconference to Resolve Protective Order Disputes - filed by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC. (Tigan, Jeremy) (Entered: 06/06/2024) (3) |
| Jun 4, 2024 | 63 | NOTICE OF SERVICE of Defendants Biophore and Zenaras First Amended Initial Disclosures Pursuant to Paragraph 3of the Default Standard for Discovery filed by Biophore India Pharmaceuticals Private Limited, Zenara Pharma Private Limited.(Weinblatt, Richard) (Entered: 06/04/2024) (3) |
| Jun 4, 2024 | 62 | SO ORDERED, re 61 Stipulation and Order to Extend Time for the parties to file a proposed protective order to June 6, 2024. Ordered by Judge Jennifer L. Hall on 6/4/2024. (ceg) (Entered: 06/04/2024) (3) |
| Jun 3, 2024 | 61 | STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to June 6, 2024 - filed by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC. (Tigan, Jeremy) (Entered: 06/03/2024) (3) |
| Jun 3, 2024 | 60 | NOTICE OF SERVICE of Plaintiffs' Identification of Accused Products and Asserted Patent Claims [to AET Pharma US, Inc.]; Plaintiffs' Identification of Accused Products and Asserted Patent Claims [to Annora Pharma Private Limited]; Plaintiffs' Identification of Accused Products and Asserted Patent Claims [to Lupin Limited and Lupin Pharmaceuticals, Inc.]; Plaintiffs' Identification of Accused Products and Asserted Patent Claims [to MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited]; Plaintiffs' Identification of Accused Products and Asserted Patent Claims [to Novitium Pharmaceuticals LLC]; Plaintiffs' Identification of Accused Products and Asserted Patent Claims [to Novugen Pharma Sdn. Bhd. and Novugen Pharma (USA) LLC]; and Plaintiffs' Identification of Accused Products and Asserted Patent Claims [to Zenara Pharma Private Limited and Biophore India Pharmaceuticals Private Limited] filed by Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC.(Tigan, Jeremy) (Entered: 06/03/2024) (10) |
| May 31, 2024 | 59 | NOTICE OF SERVICE of Initial ESI Disclosures filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Weinblatt, Richard) (Entered: 05/31/2024) (3) |
| May 25, 2024 | 58 | NOTICE OF SERVICE of (1) Initial Rule 26(a)(1) Disclosures and (2) Initial ESI Disclosures filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc..(Stamoulis, Stamatios) (Entered: 05/25/2024) (3) |
| May 23, 2024 | 57 | SO ORDERED, re 56 Stipulation and Order to Extend Time for the parties to file a proposed protective order to June 3, 2024. Signed by Judge Jennifer L. Hall on 5/23/2024. (ceg) (Entered: 05/23/2024) (3) |
| May 22, 2024 | 56 | STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to June 3, 2024 - filed by AET Pharma US, Inc.. (Gattuso, Dominick) (Entered: 05/22/2024) (3) |
| May 20, 2024 | 55 | NOTICE OF SERVICE of 1. Defendant Novitium Pharma LLC's Rule 26(a)(1) Initial Disclosures; and 2. Defendant Novitium Pharma LLC's Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Novitium Pharma LLC.(Stombaugh, Alexis) (Entered: 05/20/2024) (2) |
| May 17, 2024 | 54 | NOTICE OF SERVICE of (1) Defendants Biophore and Zenaras Initial Disclosures Pursuant to Rule 26 of the Federal Rules of Civil Procedure and (2) Defendants Biophore and Zenaras Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Biophore India Pharmaceuticals Private Limited, Zenara Pharma Private Limited.(Weinblatt, Richard) (Entered: 05/17/2024) (2) |
| May 17, 2024 | 53 | NOTICE OF SERVICE of (1) Lupin Limited and Lupin Pharmaceuticals, Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) and (2) Lupin Limited and Lupin Pharmaceuticals, Inc.'s Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) (Entered: 05/17/2024) (2) |
| May 17, 2024 | 52 | NOTICE OF SERVICE of (i) Defendant AET Pharma US, Inc.'s Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery; and, (ii) Defendant AET Pharma US, Inc.'s 26(a)1 Initial Disclosures filed by AET Pharma US, Inc..(Gattuso, Dominick) (Entered: 05/17/2024) (2) |
| May 17, 2024 | 51 | NOTICE of SERVICE of Defendant Annora Pharma Private Limited's (1) Initial Disclosures, and (2) Initial Disclosures Pursuant to Delaware's Default Standard for Discovery of Electronically Stored Information by Annora Pharma Private Limited (Cramer, Kristen) (Entered: 05/17/2024) (4) |
| May 17, 2024 | 50 | NOTICE OF SERVICE of (1) Novugen's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1); and (2) Novugen's Paragraph 3 Initial Disclosures filed by Novugen Pharma (USA) LLC, Novugen Pharma Sdn. Bhd..(Lennon, James) (Entered: 05/17/2024) (2) |
| May 17, 2024 | 49 | NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1); and (2) Plaintiffs' Paragraph 3 Initial Disclosures filed by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC.(Tigan, Jeremy) (Entered: 05/17/2024) (9) |
| May 15, 2024 | 48 | SO ORDERED, re 47 Stipulation and Order to Extend Time for the parties to file a proposed protective order to May 22, 2024. Signed by Judge Jennifer L. Hall on 5/15/2024. (ceg) (Entered: 05/15/2024) (3) |
| May 15, 2024 | 47 | STIPULATION TO EXTEND TIME for the parties to file a proposed protective order to May 22, 2024 - filed by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC. (Tigan, Jeremy) (Entered: 05/15/2024) (3) |
| May 8, 2024 | 46 | NOTICE OF SERVICE of ANDAs and API DMF, or NDA(s) at issue labeled Pitoli_0000001 Pitoli_0027182 [CONFIDENTIAL UNDER D. DEL. L. R. 26.2] filed by Biophore India Pharmaceuticals Private Limited, Zenara Pharma Private Limited.(Weinblatt, Richard) (Entered: 05/08/2024) (2) |
| May 8, 2024 | N/A | Pro Hac Vice Attorney Charles B. Klein for Biophore India Pharmaceuticals Private Limited and Zenara Pharma Private Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 05/08/2024) (0) |
| May 7, 2024 | N/A | Pro Hac Vice Attorney Annie R. Steiner for Biophore India Pharmaceuticals Private Limited and Zenara Pharma Private Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 05/07/2024) (0) |
| May 6, 2024 | 45 | NOTICE of of Withdrawal of Shashank Upadhye, Yixin Tang, and Brent Batzer by Biophore India Pharmaceuticals Private Limited, Zenara Pharma Private Limited (Weinblatt, Richard) (Entered: 05/06/2024) (3) |
| May 6, 2024 | N/A | Pro Hac Vice Attorney Alison M. King for Biophore India Pharmaceuticals Private Limited and Zenara Pharma Private Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 05/06/2024) (0) |
| May 3, 2024 | 44 | NOTICE of SERVICE of Document Production pursuant to Paragraph 8(b) of the Scheduling Order (D.I. 47) by Annora Pharma Private Limited (Cramer, Kristen) (Entered: 05/03/2024) (4) |
| May 2, 2024 | 43 | NOTICE OF SERVICE of portions of Defendant/Counterclaimant Lupin Limited's ANDA and API DMF (pursuant to Paragraph 8(b) of the Scheduling Order, D.I. 34) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Ewing, Alexandra) (Entered: 05/02/2024) (2) |
| May 2, 2024 | 42 | NOTICE OF SERVICE of documents Bates labeled NOV-PIT_0000001 - NOV-PIT_0016595 [HIGHLY CONFIDENTIAL OUTSIDE COUNSEL EYES ONLY UNDER D. DEL. L. R. 26.2] pursuant to Section 8(b) of the Scheduling Order (D.I. 34) filed by Novugen Pharma (USA) LLC, Novugen Pharma Sdn. Bhd..(Lennon, James) (Entered: 05/02/2024) (2) |
| May 1, 2024 | 41 | NOTICE OF SERVICE of Defendants MSN Laboratories Private Limited, and MSN Pharmaceuticals Inc. produced ANDA and DMF labeled MSNPIT0000001 through MSNPIT0022928 [CONFIDENTIAL OUTSIDE COUNSEL EYES ONLY UNDER D. DEL. L. R. 26.2], filed by MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. (Weinblatt, Richard) Modified on 5/2/2024 (ceg). (Entered: 05/01/2024) (2) |
| May 1, 2024 | 40 | NOTICE OF SERVICE of Defendant ANI Pharmaceuticals, Inc.'s (Novitium Pharma LLC) ANDA and DMF filed by Novitium Pharma LLC.(Stombaugh, Alexis) (Entered: 05/01/2024) (2) |
| Apr 30, 2024 | 39 | NOTICE OF SERVICE of AET Pharma US, Inc. produced documents Bates labeled AET_000000001 through AET_000006956 [HIGHLY CONFIDENTIAL OUTSIDE COUNSEL EYES' ONLY UNDER D. DEL. L. R. 26.2], pursuant to Section 8(b) of the Scheduling Order. (D.I. 34) filed by AET Pharma US, Inc..(Gattuso, Dominick) (Entered: 04/30/2024) (2) |
| Apr 30, 2024 | 38 | SO ORDERED, re 35 Stipulation and Order to Extend Certain Deadlines. Zenara and Biophore to produce their respective ANDAs and API DMF, or NDA(s) at issue due by 5/7/2024; Initial Infringement Contentions due by 7/12/2024. Signed by Judge Jennifer L. Hall on 4/30/2024. (ceg) (Entered: 04/30/2024) (2) |
| Apr 30, 2024 | N/A | SO ORDERED, re 36 Motion for Pro Hac Vice Appearance of Attorney Charles B. Klein, Jovial Wong, Alison M. King, and Annie R. Steiner filed by Biophore India Pharmaceuticals Private Limited, Zenara Pharma Private Limited. Ordered by Judge Jennifer L. Hall on 4/30/2024. (ceg) (Entered: 04/30/2024) (0) |
| Apr 29, 2024 | 35 | STIPULATION and [Proposed] Order to Extend Certain Deadlines - filed by Biophore India Pharmaceuticals Private Limited, Zenara Pharma Private Limited. (Weinblatt, Richard) Modified on 4/30/2024 (ceg). (Entered: 04/29/2024) (2) |
| Apr 29, 2024 | 36 | MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Jovial Wong, Alison M. King, and Annie R. Steiner - filed by Biophore India Pharmaceuticals Private Limited, Zenara Pharma Private Limited. (Weinblatt, Richard) (Entered: 04/29/2024) (8) |
| Apr 29, 2024 | 37 | Pro Hac Vice Fee - Credit Card Payment received for Charles B. Klein, Jovial Wong, Alison M. King, and Annie R. Steiner. ( re 36 MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Jovial Wong, Alison M. King, and Annie R. Steiner )( Payment of $ 200, receipt number ADEDC-4395504).(Weinblatt, Richard) (Entered: 04/29/2024) (0) |
| Apr 15, 2024 | 34 | SCHEDULING AND CONSOLIDATION ORDER: Harmony Biosciences, LLC et al. v. Lupin Limited et al., C.A. No. 23-1286-JLH, Harmony Biosciences, LLC et al. v. AET Pharma US, Inc. et al., C.A. No. 23-1340-JLH, and Harmony Biosciences, LLC et al. v. MSN Pharms. Inc. et al., C.A. No. 23-1420-JLH, are consolidated for all purposes up to and including trial. Joinder of Parties due by 8/30/2024. Amended Pleadings due by 8/30/2024. Joint Claim Construction Brief due by 1/8/2025. A Markman Hearing is set for 3/27/2025 at 10:00 AM in Courtroom 6D before Judge Jennifer L. Hall. Interim Status Report due by 4/2/2025. Fact Discovery completed by 4/18/2025. Expert Discovery completed by 10/30/2025. Proposed Pretrial Order due by 1/14/2026. A Pretrial Conference is set for 1/21/2026 at 10:00 AM in Courtroom 6D before Judge Jennifer L. Hall. A 4-day Bench Trial is set for 2/17/2026 at 09:30 AM in Courtroom 6D before Judge Jennifer L. Hall. (*See Order for details). Signed by Judge Jennifer L. Hall on 4/15/2024. Associated Cases: 1:23-cv-01286-JLH, 1:23-cv-01340-JLH, 1:23-cv-01420-JLH(ceg) (Main Document 34 replaced on 4/15/2024) (ceg). (Entered: 04/15/2024) (17) |
| Apr 8, 2024 | 33 | Joint PROPOSED Scheduling and Order re (23 in 1:23-cv-01420-JLH), (36 in 1:23-cv-01340-JLH), (27 in 1:23-cv-01286-JLH) Order, by Bioprojet Pharma SAS, Bioprojet Socite Civile de Recherche, Harmony Biosciences, LLC, Bioprojet Societe Civile de Recherche. (Attachments: # 1 Cover Letter to the Honorable Jennifer L. Hall)(Tigan, Jeremy) Modified on 4/8/2024 (ceg). (Entered: 04/08/2024) (0) |
| Apr 8, 2024 | N/A | SO ORDERED, re 31 Motion for Pro Hac Vice Appearance of Attorney Paul J. Molino, Katie A. Boda, Kevin E. Warner, and Wojciech K. Jankiewicz filed by Novugen Pharma (USA) LLC, Novugen Pharma Sdn. Bhd. Ordered by Judge Jennifer L. Hall on 4/8/2024. (ceg) (Entered: 04/08/2024) (0) |
| Apr 5, 2024 | 32 | Pro Hac Vice Fee - Credit Card Payment received for Paul J. Molino, Katie A. Boda, Kevin E. Warner, and Wojciech K. Jankiewicz. ( re 31 MOTION for Pro Hac Vice Appearance of Attorney Paul J. Molino, Katie A. Boda, Kevin E. Warner, and Wojciech K. Jankiewicz )( Payment of $ 200, receipt number ADEDC-4378937).(Lennon, James) (Entered: 04/05/2024) (0) |
| Apr 5, 2024 | 31 | MOTION for Pro Hac Vice Appearance of Attorney Paul J. Molino, Katie A. Boda, Kevin E. Warner, and Wojciech K. Jankiewicz - filed by Novugen Pharma (USA) LLC, Novugen Pharma Sdn. Bhd.. (Lennon, James) (Entered: 04/05/2024) (6) |
| Apr 5, 2024 | 30 | SO ORDERED, re (44 in 1:23-cv-01340-JLH, 29 in 1:23-cv-01286-JLH, 27 in 1:23-cv-01420-JLH) Stipulation and Order to Extend Time for the parties to file a joint proposed scheduling order and letter to April 8, 2024. Signed by Judge Jennifer L. Hall on 4/5/2024. Associated Cases: 1:23-cv-01286-JLH, 1:23-cv-01340-JLH, 1:23-cv-01420-JLH(ceg) (Entered: 04/05/2024) (3) |
| Apr 4, 2024 | 29 | STIPULATION TO EXTEND TIME for the parties to file a joint proposed scheduling order and letter pursuant to the Court's Oral Orders (C.A. No. 23-1286, D.I. 27; C.A. No. 23-1340, D.I. 36; C.A. No. 23-1420, D.I. 23) to April 8, 2024 - filed by Bioprojet Pharma SAS, Bioprojet Socite Civile de Recherche, Harmony Biosciences, LLC, Bioprojet Societe Civile de Recherche. (Tigan, Jeremy) (Entered: 04/04/2024) (3) |
| Mar 18, 2024 | 28 | ANSWER to 19 Answer to Complaint, Counterclaim (Plaintiffs' Answer to Lupin Limited's Counterclaims), by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC. (Tigan, Jeremy) Modified on 3/18/2024 (ceg). (Entered: 03/18/2024) (10) |
| Mar 5, 2024 | 27 | ORAL ORDER: IT IS HEREBY ORDERED that, within thirty days, the parties shall jointly prepare and file the following: (i) a proposed Scheduling Order consistent with Judge Hall's "Rule 16 Scheduling Order - Patent", and (ii) a letter, not to exceed three pages, setting forth (a) the parties' positions regarding any disputes in the proposed Scheduling Order and (b) a list of any other issues the parties want to address at the Rule 16 Scheduling Conference. Thereafter, the Court may schedule a Rule 16 Scheduling Conference to be held with Judge Hall. The Scheduling Order can be found on Judge Hall's portion of the District Court's website. Ordered by Judge Jennifer L. Hall on 3/5/2024. (ceg) (Entered: 03/05/2024) (0) |
| Mar 5, 2024 | 26 | SO ORDERED, re 23 Stipulation and Order Dismissing Complaint as to Defendant Makro Technologies Inc. and Amendment of Caption. Signed by Judge Jennifer L. Hall on 3/5/2024. (ceg) (Entered: 03/05/2024) (4) |
| Mar 4, 2024 | 25 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent SciTech International DMCC for Novugen Pharma Sdn. Bhd. filed by Novugen Pharma (USA) LLC, Novugen Pharma Sdn. Bhd.. (Lennon, James) (Entered: 03/04/2024) (2) |
| Mar 4, 2024 | 24 | ANSWER to 1 Complaint, by Novugen Pharma (USA) LLC, Novugen Pharma Sdn. Bhd..(Lennon, James) (Entered: 03/04/2024) (30) |
| Mar 4, 2024 | 23 | STIPULATION and [Proposed] Order Dismissing Complaint as to Defendant Makro Technologies Inc. and Amendment of Caption - by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC. (Blumenfeld, Jack) (Entered: 03/04/2024) (4) |
| Feb 29, 2024 | N/A | Pro Hac Vice Attorneys William O. Adams, Brian C. Barnes, and William R. Zimmerman for Lupin Limited and Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 02/29/2024) (0) |
| Feb 26, 2024 | N/A | SO ORDERED, re 21 Motion for Pro Hac Vice Appearance of Attorney William R. Zimmerman, William O. Adams and Brian C. Barnes filed by Lupin Limited, Lupin Pharmaceuticals, Inc. Ordered by Judge Jennifer L. Hall on 2/26/2024. (ceg) (Entered: 02/26/2024) (0) |
| Feb 26, 2024 | 22 | Pro Hac Vice Fee - Credit Card Payment received for William R. Zimmerman, William O. Adams, and Brian C. Barnes. ( re 21 MOTION for Pro Hac Vice Appearance of Attorney William R. Zimmerman, William O. Adams and Brian C. Barnes )( Payment of $ 150, receipt number ADEDC-4347593).(Cottrell, Frederick) (Entered: 02/26/2024) (0) |
| Feb 26, 2024 | 21 | MOTION for Pro Hac Vice Appearance of Attorney William R. Zimmerman, William O. Adams and Brian C. Barnes - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Cottrell, Frederick) (Entered: 02/26/2024) (6) |
| Feb 26, 2024 | 20 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lupin, Inc. for Lupin Pharmaceuticals, Inc. filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Cottrell, Frederick) (Entered: 02/26/2024) (2) |
| Feb 26, 2024 | 19 | ANSWER to 1 Complaint, COUNTERCLAIM against Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC by Lupin Pharmaceuticals, Inc., Lupin Limited. (Cottrell, Frederick) Modified on 2/26/2024 (ceg). (Entered: 02/26/2024) (30) |
| Feb 2, 2024 | N/A | SO ORDERED, re 18 Joint Stipulation and Order to Extend Time to file Answer to Plaintiffs' Complaint to March 4, 2024. (*Reset Answer Deadlines: Makro Technologies Inc. answer due 3/4/2024; Novugen Pharma (USA) LLC answer due 3/4/2024; Novugen Pharma Sdn. Bhd. answer due 3/4/2024. Ordered by Judge Jennifer L. Hall on 2/2/2024. (ceg) (Entered: 02/02/2024) (0) |
| Feb 2, 2024 | 18 | Joint STIPULATION TO EXTEND TIME to file the Answer to Plaintiffs' Complaint to March 4, 2024 - filed by Makro Technologies Inc., Novugen Pharma (USA) LLC, Novugen Pharma Sdn. Bhd.. (Lennon, James) (Entered: 02/02/2024) (2) |
| Jan 9, 2024 | N/A | Case Reassigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. Associated Cases: 1:23-cv-01286-JLH, 1:23-cv-01340-JLH, 1:23-cv-01420-JLH (rjb) (Entered: 01/09/2024) (0) |
| Dec 21, 2023 | N/A | SO ORDERED re (15 in 1:23-cv-01340-MN, 17 in 1:23-cv-01286-MN) MOTION for Pro Hac Vice Appearance of Attorney Pierre Anquetil filed by Harmony Biosciences, LLC, Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche. ORDERED by Judge Maryellen Noreika on 12/21/2023. (dlw) (Entered: 12/21/2023) (0) |
| Dec 21, 2023 | 17 | MOTION for Pro Hac Vice Appearance of Attorney Pierre Anquetil - filed by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC. (Tigan, Jeremy) (Entered: 12/21/2023) (5) |
| Dec 7, 2023 | 16 | SO ORDERED re 15 STIPULATION and Order to Extend Time to move, answer, or otherwise respond to Plaintiffs' Complaint to February 26, 2024 (Set/Reset Answer Deadlines: Lupin Limited answer due 2/26/2024. Lupin Pharmaceuticals, Inc. answer due 2/26/2024). Signed by Judge Maryellen Noreika on 12/7/2023. (dlw) (Entered: 12/07/2023) (2) |
| Dec 7, 2023 | 15 | STIPULATION TO EXTEND TIME and [Proposed] Order to respond to Plaintiffs' Complaint to February 26, 2024 - filed by Lupin Pharmaceuticals, Inc.. (Ewing, Alexandra) (Entered: 12/07/2023) (2) |
| Dec 7, 2023 | 14 | NOTICE of Appearance by Alexandra M. Ewing on behalf of Lupin Limited, Lupin Pharmaceuticals, Inc. (Ewing, Alexandra) (Entered: 12/07/2023) (1) |
| Dec 7, 2023 | 13 | NOTICE of Appearance by Frederick L. Cottrell, III on behalf of Lupin Limited, Lupin Pharmaceuticals, Inc. (Cottrell, Frederick) (Entered: 12/07/2023) (1) |
| Dec 7, 2023 | N/A | SO ORDERED re (12 in 1:23-cv-01286-MN, 13 in 1:23-cv-01340-MN) MOTION for Pro Hac Vice Appearance of Attorney Christopher N. Sipes, Erica N. Andersen, Brianne Bharkhda, Sarahi Uribe, Elaine H. Nguyen, and Yiye Fu filed by Harmony Biosciences, LLC, Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche. ORDERED by Judge Maryellen Noreika on 12/7/2023. (dlw) (Entered: 12/07/2023) (0) |
| Dec 6, 2023 | 12 | MOTION for Pro Hac Vice Appearance of Attorney Christopher N. Sipes, Erica N. Andersen, Brianne Bharkhda, Sarahi Uribe, Elaine H. Nguyen, and Yiye Fu - filed by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC. (Tigan, Jeremy) (Entered: 12/06/2023) (9) |
| Dec 1, 2023 | N/A | SO ORDERED, re 11 Joint STIPULATION TO EXTEND TIME for defendant Makro Technologies Inc. to respond to the Complaint to February 20, 2024. Set/Reset Answer Deadlines: Makro Technologies Inc. answer due 2/20/2024. ORDERED by Judge Maryellen Noreika on 12/1/2023. (mdb) (Entered: 12/01/2023) (0) |
| Dec 1, 2023 | 11 | Joint STIPULATION TO EXTEND TIME for defendant Makro Technologies Inc. to respond to the Complaint to February 20, 2024 - filed by Makro Technologies Inc., Novugen Pharma (USA) LLC, Novugen Pharma Sdn. Bhd.. (Lennon, James) (Entered: 12/01/2023) (2) |
| Nov 30, 2023 | 10 | WAIVER OF SERVICE returned executed by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC: For Lupin Pharmaceuticals, Inc. waiver sent on 11/28/2023, answer due 2/26/2024. (Tigan, Jeremy) (Entered: 11/30/2023) (1) |
| Nov 30, 2023 | 9 | WAIVER OF SERVICE returned executed by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC: For Lupin Limited waiver sent on 11/28/2023, answer due 2/26/2024. (Tigan, Jeremy) (Entered: 11/30/2023) (1) |
| Nov 29, 2023 | N/A | SO ORDERED, re 8 Joint STIPULATION TO EXTEND TIME for the Novugen defendants to respond to the Complaint to February 20, 2024. Set/Reset Answer Deadlines: Novugen Pharma (USA) LLC answer due 2/20/2024; Novugen Pharma Sdn. Bhd. answer due 2/20/2024. Ordered by Judge Maryellen Noreika on 11/29/2023. (as) (Entered: 11/29/2023) (0) |
| Nov 29, 2023 | 8 | Joint STIPULATION TO EXTEND TIME for the Novugen defendants to respond to the Complaint to February 20, 2024 - filed by Novugen Pharma (USA) LLC, Novugen Pharma Sdn. Bhd.. (Lennon, James) (Entered: 11/29/2023) (2) |
| Nov 15, 2023 | N/A | Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) (Entered: 11/15/2023) (0) |
| Nov 9, 2023 | 7 | Summons Issued as to Lupin Limited, Lupin Pharmaceuticals, Inc., Makro Technologies Inc., Novugen Pharma (USA) LLC, and Novugen Pharma Sdn. Bhd. (Attachments: # 1 Summons Issued, # 2 Summons Issued, # 3 Summons Issued, # 4 Summons Issued) (mkr) (Entered: 11/13/2023) (0) |
| Nov 9, 2023 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Harmony Biosciences Holdings, Inc. for Harmony Biosciences, LLC filed by Harmony Biosciences, LLC. (mkr) (Entered: 11/13/2023) (2) |
| Nov 9, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bioprojet Societe Civile de Recherche for Bioprojet Pharma SAS filed by Bioprojet Pharma SAS, and Bioprojet Societe Civile de Recherche. (mkr) (Entered: 11/13/2023) (2) |
| Nov 9, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,486,947 B2; 8,207,197 B2. (mkr) (Entered: 11/13/2023) (1) |
| Nov 9, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/28/2023. Date of Expiration of Patent: U.S. Patent No. 8,486,947 expires on 9/26/2029; and U.S. Patent No. 8,207,197 expires on 3/7/2030.Thirty Month Stay Deadline: 2/14/2027. (mkr) (Entered: 11/13/2023) (1) |
| Nov 9, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mkr) (Entered: 11/13/2023) (3) |
| Nov 9, 2023 | 1 | Complaint* (1) |
